This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Study Examining Long Response in Lung Cancer Pat...
Clinical trial

A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)

Read time: 1 mins
Last updated:7th May 2014

This multicenter, retrospective and prospective observational, cohort study will examine the effect of second-line Tarceva treatment on long response in NSCLC patients with wild type or unknown EGFR status. Patients will be observed from the start of treatment for 8 months or until death. The extension of the retrospective versus prospective observation will depend on the lag between the date of the patient enrollment and the date of beginning of erlotinib therapy.

Category Value
Study start date 2014-05-07

View full details